Savita Khosla, MD
Gynecology · Hackensack, NJNPI 1265424238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.
Across 55 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$126
- Mayne Pharma Commercial LLC$121
- Bayer$117
- AbbVie$115
- Astellas Pharma US Inc$80
- Evofem Biosciences, Inc.$60
- plus $161 from 9 others
What the payments were for
- Food & beverage$780100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 9 | $126 |
| Mayne Pharma Commercial LLC | 12 | $121 |
| Bayer | 5 | $117 |
| AbbVie | 9 | $115 |
| Astellas Pharma US Inc | 4 | $80 |
| Evofem Biosciences, Inc. | 4 | $60 |
| Avion Pharmaceuticals | 3 | $40 |
| Coopersurgical, Inc. | 2 | $27 |
| Mycovia Pharmaceuticals, Inc. | 1 | $16 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Amgen | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Lupin Inc. | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
How this compares
$780 in reported general payments places this provider in the 60th percentile of 97 gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,368 |
| Clobetasol Propionate | 18 | $649 |
| ValacyclovirValacyclovir Hcl | 13 | $403 |
| Junel FeNorethindrone-E.Estradiol-Iron | 16 | $334 |
| Fluconazole | 24 | $116 |
| Alendronate Sodium | 12 | $114 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Hackensack
- Barbara CavallaroHackensack$811
- David LeeHackensack$474
- James TursiLumberton$217K
- Marco PelosiBayonne$164K
- Heather van RaaltePrinceton$140K
- Scott EderPrinceton$124K
- Michael VardyEnglewood$114K
- Daryl BoffardUnion$55K
- Shyama MathewsPlainsboro$54K
- Lora LiuJersey City$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.